<amendment session="114" chamber="h" number="662" updated="2019-01-25T19:28:14Z">
  <amends type="h" number="6" sequence=""/>
  <status datetime="2015-07-10">offered</status>
  <sponsor bioguide_id="P000598"/>
  <offered datetime="2015-07-10"/>
  <description>Page 235, insert after line 2 the following new subtitle:    Subtitle R--Other Provisions    SEC. 2321. STUDY ON TWO-TIERED APPROVAL PROCESS FOR DEVICES BY FDA.***.</description>
  <purpose>An amendment numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.</purpose>
  <actions>
    <action datetime="2015-07-10T10:27:00-04:00">
      <text>By unanimous consent, the Polis amendment was withdrawn.</text>
      <reference ref="CR H5078" label="consideration"/>
    </action>
    <action datetime="2015-07-10T10:18:55-04:00">
      <text>Amendment (A007) offered by Mr. Polis.</text>
      <reference ref="CR H5077-5078" label="consideration"/>
      <reference ref="CR H5077" label="text"/>
    </action>
    <action datetime="2015-07-10"/>
    <action datetime="2015-07-10T10:18:55-04:00">
      <text>House amendment offered/reported by : Amendment (A007) offered by Mr. Polis.</text>
      <reference ref="CR H5077-5078" label="consideration"/>
      <reference ref="CR H5077" label="text"/>
    </action>
    <action datetime="2015-07-10">
      <text>House amendment offered</text>
    </action>
  </actions>
</amendment>
